Trial Profile
Clinical efficay, pharmacokinetics and pharmacodynamics, and intra-subject variability of insulin Glargine U-300 vs Glargine U-100 in type 1 diabetes. Clinical efficay, pharmacokinetics and pharmacodynamics, and intra-subject variability of insulin Glargine U-300 vs Glargine U-100 in type 1 diabetes
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 24 Dec 2020
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- 16 Jun 2020 Results assessing improved glycemic control with Insulin Glargine 300 U/mL versus Glargine 100 U/mL in Type 1 diabetes presented at the 80th Annual Scientific Sessions of the American Diabetes Association
- 10 Oct 2018 Results published in the Diabetes Care
- 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes